Loading...

Profound Medical Corp.

PRN.TOTSX
Healthcare
Medical - Devices
CA$8.23
CA$0.00(0.00%)

Profound Medical Corp. (PRN.TO) Company Profile & Overview

Explore Profound Medical Corp.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Profound Medical Corp. (PRN.TO) Company Profile & Overview

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.

SectorHealthcare
IndustryMedical - Devices
CEOArun Swarup Menawat MBA,

Contact Information

647 476 1350
2400 Skymark Avenue, Mississauga, ON, L4W 5K5

Company Facts

142 Employees
IPO DateJul 10, 2018
CountryCA
Actively Trading

Frequently Asked Questions

;